Essential Reading on Prevention and Treatment of Hepatitis B

Author: Yang Xi
Publisher:
Publish Date: 2003-04-01
Features: The harm of chronic hepatitis lies in two aspects: it can transmit the hepatitis B virus through blood to others, and it can trigger liver fibrosis. Observations show that approximately 65% of moderate chronic hepatitis cases have fibrosis, while 100% of severe chronic hepatitis cases do. This can lead to cirrhosis. If left untreated, it may progress to late-stage complications such as ascites, esophageal variceal rupture bleeding, and hepatic encephalopathy. A 5-year follow-up study indicates that the incidence of cirrhosis in chronic hepatitis B patients ranges from 2% to 20%. Compensated cirrhosis can progress to decompensated cirrhosis at a rate of 20% to 23%. It can also develop into liver cancer at a rate of 6% to 15%. According to surveys and calculations, 25% to 40% of chronic hepatitis B patients in China will eventually develop cirrhosis or concurrent liver cancer. It is evident that the hepatitis B virus and its widespread transmission have become a major health issue for humanity today. This book, in the form of a popular science publication, introduces readers to the onset, harm, and overview of hepatitis B, the correct understanding of hepatitis B, common misconceptions in the diagnosis and treatment of hepatitis B, the prevention and treatment of hepatitis B, the diagnosis and treatment of hepatitis B carriers, as well as the prevention and treatment of complications and associated diseases of hepatitis B. The content is systematic, novel, detailed, and practical, making it suitable for the general public, especially patients with hepatitis B. It also holds certain reference value for clinical physicians.